Diagnostics play Genetron raises $75M, looks to NASDAQ for China expansion

Seeking to expand its cancer diagnostics business in China, Genetron proposed a NASDAQ IPO and announced completion of venture financing that together could bring the company up to $175 million.

Beijing-based Genetron Holdings Ltd. raised a total of $75 million Tuesday in

Read the full 410 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers